Investigación

Evaluación de Tecnologías Sanitarias en Atención Primaria y Salud Mental (PRISMA)

Buscador de publicaciones

Publicaciones

  • Sanabria JP, Doval E, Bernadàs A, Angarita-Osorio N, Colomer A, Evans-Lacko S, Thornicroft G, Luciano JV and Rubio-Valera M.

    Over 40 years (1981-2023) assessing stigma with the Community Attitudes to Mental Illness (CAMI) scale: a systematic review of its psychometric properties

    Systematic Reviews . 12(1): 66-66. Nº de citas: 7

    [doi:10.1186/s13643-023-02230-4]

  • Lavalle R, Condominas E, Haro JM, Giné I, Bailon R, Laporta E, Garcia E, Kontaxis S, Alacid GR, Lombardini F, Preti A, Peñarrubia-María MT, Coromina M, Arranz B, Vilella E, Rubio E, Radar-Mdd Spain, Matcham F, Lamers F, Hotopf M, Penninx BWJH, Annas P, Narayan V, Simblett SK, Siddi S and The Radar-Cns Consortium.

    The Impact of COVID-19 Lockdown on Adults with Major Depressive Disorder from Catalonia: A Decentralized Longitudinal Study.

    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH . 20(6): .

    [doi:10.3390/ijerph20065161]

  • Kardas, P, Agh, T, Dima AL, Goetzinger, C, Potocnjak, I, Wettermark, B and van Boven, JFM.

    Half a Century of Fragmented Research on Deviations from Advised Therapies: Is This a Good Time to Call for Multidisciplinary Medication Adherence Research Centres of Excellence?

    Pharmaceutics . 15(3): . Nº de citas: 3

    [doi:10.3390/pharmaceutics15030933]

  • Cuñat O, Del Hoyo-Buxo B, Vila R, Serra C, Butjosa A, del Cacho N, Colomer A, Dolz M, Cuevas-Esteban J, Iglesias M, Usall J and Profep Group.

    Negative symptoms in drug-naive patients with a first-episode psychosis (FEP)

    Asian Journal of Psychiatry . 81: 103448-103448. Nº de citas: 1

    [doi:10.1016/j.ajp.2023.103448]

  • Bhattacharya D, Brown TJ, Clark AB, Dima AL, Easthall C, Taylor N and Li Z.

    Validation of the Identification of Medication Adherence Barriers Questionnaire (IMAB-Q) ; a Behavioural Science-Underpinned Tool for Identifying Non-Adherence and Diagnosing an Individual's Barriers to Adherence

    PATIENT PREFERENCE AND ADHERENCE . 17: 2991-3000. Nº de citas: 1

    [doi:10.2147/PPA.S427207]

  • Arias de la Torre J, Gemma Vilagut Saiz, Ronaldson A, Bakolis I, Dregan A, Navarro-Mateu F, Pérez K, Szücs A, Bartoll-Roca X, Molina AJ, Elices M, Pérez-Solá V, Martín V, Serrano-Blanco A, Valderas JM and Alonso J.

    Reconsidering the Use of Population Health Surveys for Monitoring of Mental Health

    JMIR Public Health and Surveillance . 9: 48138-48138. Nº de citas: 1

    [doi:10.2196/48138]

  • Viprey M, Mougeot F, Dima AL, Haesebaert J, Occelli P, Durieu I, Rouzé H, Reynaud Q and Touzet S.

    A Participatory Approach Involving Patients with Cystic Fibrosis and Healthcare Professionals for the Co-Design of an Adherence-Enhancing Intervention Toolkit

    PATIENT PREFERENCE AND ADHERENCE . 17: 995-1004.

    [doi:10.2147/PPA.S389792]

  • Fuente M, Clara García Terol, Domínguez-Salas S, Rubio-Valera M and Motrico E.

    Maternity care changes and postpartum mental health during the COVID-19 pandemic: a Spanish cross-sectional study

    JOURNAL OF REPRODUCTIVE AND INFANT PSYCHOLOGY . 42(4): 1-16. Nº de citas: 2

    [doi:10.1080/02646838.2023.2171375]

  • Vázquez ML, Vargas I, Rubio-Valera M, Aznar I, Eguiguren P, Mogollón-Pérez AS, Torres AL, Peralta A, Dias S and Jervelund SS.

    Improving equity in access to early diagnosis of cancer in different healthcare systems of Latin America: protocol for the EquityCancer-LA implementation-effectiveness hybrid study.

    BMJ Open . 12(12): .

    [doi:10.1136/bmjopen-2022-067439]

  • Corral C, Sanchez A, Gil MM, Peñarrubia-María MT, Aznar I, Serrano-Blanco A, Carbonell-Duacastella C, Gallardo MC, Mari Carmen Olmos Palenzuela and Rubio-Valera M.

    Improving Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care: Pilot trial of a complex intervention.

    Frontiers in public health . 10: 1038138-1038138. Nº de citas: 3

    [doi:10.3389/fpubh.2022.1038138]